# Open-Label,Non-Randomized Trial of Cisplatin Chemotherapy in BRCA1-Positive Metastatic Breast Cancer Patients

> **NCT01611727** · PHASE2 · COMPLETED · sponsor: **Pomeranian Medical University Szczecin** · enrollment: 20 (actual)

## Conditions studied

- BRCA1 Mutation
- Metastatic Breast Cancer

## Interventions

- **DRUG:** Cisplatin

## Key facts

- **NCT ID:** NCT01611727
- **Lead sponsor:** Pomeranian Medical University Szczecin
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2009-01
- **Final completion:** 2009-04
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2012-07-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01611727

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01611727, "Open-Label,Non-Randomized Trial of Cisplatin Chemotherapy in BRCA1-Positive Metastatic Breast Cancer Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01611727. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*